🔗 Share this article

A shadow economy for unapproved slimming drugs is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these profiles directly for supplier links, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and claims of next-day British shipping. Sellers market the substance there before directing buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, doctors and chemists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in individuals injecting products of uncertain source.

Several professionals said the demand for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Some influencers try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment.

Service Response and Content Removal

According to TikTok, the platform has taken down violative content and banned related keywords and search suggestions. The company stated it was dedicated to keeping the platform secure and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Research also found communities with up to 9,000 members selling retatrutide using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of members, filled with photos of slimming results, glowing testimonials and step-by-step guides for preparing or injecting at home.

After minutes of joining one community, a vendor posted contact information, where most transactions occur. The vendor provided an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Item Details and Pricing

Inside these communities, posts show black plastic parcels with postal service labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or pre-filled pens typically sold at £160 for 20mg. When asked how long a pen should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A representative for the messaging service stated it actively moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they cannot confirm. Even if the science behind this drug is sound, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has already seen individuals harmed by self-injection from unverified suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may expose users to possibly significant medical dangers”.